kabutan

ASKA Pharmaceutical Holdings Co.,Ltd.(4886) Summary

4886
TSE Prime
ASKA Pharmaceutical Holdings Co.,Ltd.
2,484
JPY
+81
(+3.37%)
Feb 16, 2:47 pm JST
16.21
USD
Feb 16, 12:47 am EST
Result
PTS
outside of trading hours
2,482
Feb 16, 2:47 pm JST
Summary Chart Historical News Financial Result
PER
14.1
PBR
1.03
Yield
2.21%
Margin Trading Ratio
14.39
Stock Price
Feb 16, 2026
Opening Feb 16, 9:00 am
2,410 JPY 15.77 USD
Previous Close Feb 13
2,403 JPY 15.68 USD
High Feb 16, 2:21 pm
2,490 JPY 16.25 USD
Low Feb 16, 9:00 am
2,402 JPY 15.72 USD
Volume
197,800
Trading Value
0.49B JPY 3.17M USD
VWAP
2455.51 JPY 16.03 USD
Minimum Trading Value
248,400 JPY 1,621 USD
Market Cap
0.07T JPY 0.47B USD
Number of Trades
683
Liquidity & Number of Trades
As of Feb 16, 2026
Liquidity
Mid
1-Year Average
304
1-Year High Jan 29, 2026
3,529
Margin Trading
Date Short Interest Long Margin Positions Ratio
Feb 6, 2026 51,600 629,200 12.19
Jan 30, 2026 107,200 556,200 5.19
Jan 23, 2026 27,300 196,500 7.20
Jan 16, 2026 20,500 114,200 5.57
Jan 9, 2026 15,900 120,200 7.56
Company Profile
ASKA Pharmaceutical Holdings Co., Ltd. specializes in gynecology and urology, with hormone preparations as its main products. The company sells generic drugs for Takeda and also develops new drugs.
Sector
Pharmaceuticals
ASKA Pharmaceutical Holdings Co., Ltd. focuses on the pharmaceutical business as its core, while also operating in animal health and clinical testing sectors. In the pharmaceutical business, "Aska Pharmaceutical" specializes in products for internal medicine, obstetrics and gynecology, and urology, which are distributed through Takeda Pharmaceutical Company. The animal health business is managed by "Aska Animal Health," which procures some products from Aska Pharmaceutical while also outsourcing manufacturing to Aska Pharmaceutical. The clinical testing business is operated by "Aska Pharmaceutical Medical," which leases facilities from Aska Pharmaceutical for its operations. Additionally, Aska Pharmaceutical handles the procurement and sales of medical devices and health foods. The company has adopted a holding company structure to manage its group companies effectively.